| 2017-COOK-67947 | |
| In vitro and in vivo isomerization of aspartate (Asp) to isoaspartate (isoAsp) is one of the main routes to protein degradation. Deamidation of asparagine (Asn) can also yield isoAsp via a common succinimide intermediate. Not only can this transformation change the structure and activity of a protein, it can also lead to immunological response. Furthermore, an increase in endogenous isoAsp has been linked to Alzheimer's disease and aging. The body naturally produces enzymes that work to reduce the levels of isoAsp, namely PIMT and PCMT, both of which methylate isoAsp to encourage isomerization to Asp. The spontaneous, post-translational generation of isoAsp poses an immediate problem to the development of protein-bound pharmaceuticals, where shelf life and activity may be directly affected; in fact, isoAsp generation is one of the most common contributors to heterogeneity in a protein-bound drug. Factors that induce the generation of isoAsp include pH, secondary and tertiary protein structure, and formulation. Researchers at Purdue University have developed a fast and inexpensive method to determine isoaspartate by chemical derivatization in the backbones of peptides by ionizing labeled peptides. This method is the simplest and most accessible assay for isoAsp determination, which makes it useful to researchers studying its link to disease or drug-bioconjugate degradation. Advantages: -Fast -Inexpensive -Easily accessible Potential Applications: -Research related to isoAsp's link to disease or drug-bioconjugate degradation -Medical/Health -Pharmaceutical industry |
|
|
|
|
Jun 7, 2018
Utility Patent
United States
10,908,165
Feb 2, 2021
Jan 26, 2021
CON-Patent
United States
(None)
(None)
Jun 7, 2017
Provisional-Patent
United States
(None)
(None)
|
|
|
Purdue Office of Technology Commercialization The Convergence Center 101 Foundry Drive, Suite 2500 West Lafayette, IN 47906 Phone: (765) 588-3475 Fax: (765) 463-3486 Email: otcip@prf.org |